These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 15902847)
1. Platelet adhesion in hypertension: application of a novel assay of platelet adhesion. Nadar SK; Caine GJ; Blann AD; Lip GY Ann Med; 2005; 37(1):55-60. PubMed ID: 15902847 [TBL] [Abstract][Full Text] [Related]
2. Platelet adhesion in breast cancer: development and application of a novel assay. Caine GJ; Nadar SK; Lip GY; Stonelake PS; Blann AD Blood Coagul Fibrinolysis; 2004 Sep; 15(6):513-8. PubMed ID: 15311162 [TBL] [Abstract][Full Text] [Related]
3. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941 [TBL] [Abstract][Full Text] [Related]
4. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Chung I; Choudhury A; Patel J; Lip GY Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353 [TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631 [TBL] [Abstract][Full Text] [Related]
6. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113 [TBL] [Abstract][Full Text] [Related]
8. Platelet activation in pregnancy-induced hypertension. Karalis I; Nadar SK; Al Yemeni E; Blann AD; Lip GY Thromb Res; 2005; 116(5):377-83. PubMed ID: 16122550 [TBL] [Abstract][Full Text] [Related]
9. Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Spencer CG; Gurney D; Felmeden DC; Blann AD; Beevers DG; Lip GY J Intern Med; 2004 Jan; 255(1):59-67. PubMed ID: 14687239 [TBL] [Abstract][Full Text] [Related]
10. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation. Varughese GI; Patel JV; Tomson J; Lip GY Heart; 2007 Apr; 93(4):495-9. PubMed ID: 17005711 [TBL] [Abstract][Full Text] [Related]
11. Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension. Yang P; Liu YF; Yang L; Wei Q; Zeng H Clin Cardiol; 2010 Jun; 33(6):E81-6. PubMed ID: 20552613 [TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY; Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139 [TBL] [Abstract][Full Text] [Related]
13. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791 [TBL] [Abstract][Full Text] [Related]
14. Study of platelet adhesion in patients with uncomplicated hypertension. Andrioli G; Ortolani R; Fontana L; Gaino S; Bellavite P; Lechi C; Minuz P; Manzato F; Tridente G; Lechi A J Hypertens; 1996 Oct; 14(10):1215-21. PubMed ID: 8906521 [TBL] [Abstract][Full Text] [Related]
15. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416 [TBL] [Abstract][Full Text] [Related]
16. Divalent cations and the protein surface co-ordinate the intensity of human platelet adhesion and P-selectin surface expression. Whiss PA; Andersson RG Blood Coagul Fibrinolysis; 2002 Jul; 13(5):407-16. PubMed ID: 12138368 [TBL] [Abstract][Full Text] [Related]
17. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848 [TBL] [Abstract][Full Text] [Related]
18. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. Li-Saw-Hee FL; Blann AD; Lip GY J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245 [TBL] [Abstract][Full Text] [Related]
19. Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate. Fägerstam JP; Ostberg AK; Eriksson AC; Fransson SG; Whiss PA Br J Radiol; 2010 May; 83(989):401-10. PubMed ID: 19546176 [TBL] [Abstract][Full Text] [Related]